Mass Spectrometry in Biopharmaceutical and Emerging Drug Modalities

Angebote / Angebote:

Over the past ten years the pharmaceutical industry has investigated the development of drugs from biological molecules, e.g. proteins, which, due to their complexity, has been enabled by the very rapid advances in mass spectrometry (MS) and experimental approaches. This book provides a review of the state of the art for the in-depth characterization of these complex treatment modalities. Coverage focuses on the use of mass spectrometry for the assessment of alternative modes of drug efficacy and their quality alongside the inclusion of information on the use of MS in the development of protein biosimilars. Providing a unique and up to date addition to the literature in this area, this book is aimed at researchers, both new and established, looking into the applications of MS in the pharmaceutical industry.

Fremdlagertitel. Lieferzeit unbestimmt